Fact CheckerSign in

NCT05014256Completed

System Interventions to Achieve Early and Equitable Transplants (STEPS) Study

Source: ClinicalTrials.gov · Last updated 2 Oct 2026

Brief summary (registry, in English)

This project will study how kidney care for everyone despite race can reduce racial differences in care and improve access to kidney transplants, and specifically living donor kidney transplants (LDKT), for individuals with chronic kidney disease. A study focused on equality and patient needs (called 'STEPS') will 1) create a program to identify people who may need a kidney transplant ('STEPS Surveillance') and find people in health systems who may be able to receive kidney transplants early in their care and (2) study how well the 'STEPS Outreach' program works (comprised of transplant social workers and transplant coordinators who focus on equality and patient needs) compared to usual care to improve access to kidney transplants among Black and non-Black individuals as well as to improve access to transplants for everyone.

Status (registry)
Completed
Study type
Interventional
Enrollment
1168 (actual)
First submitted
13 Aug 2021
Start date
2 Apr 2022
Primary completion date
31 Dec 2025
Lead sponsor
Wake Forest University Health Sciences
NCT number
NCT05014256

What you commit to

  • Study type: Interventional
  • Participants enrolled: 1168
  • From 2 Apr 2022 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior kidney transplant
  • Currently waitlisted at any transplant center

Other illness

  • Self-reported terminal illness or receipt of hospice services

Age

  • Male or female, aged \<18 or \> 75 years

Other

  • Non-English speaking
  • Lack of ability to hear and comprehend verbal communication.
  • Patients on dialysis
  • Deceased
  • Hospice/palliative care

Who the study is looking for

  • Ability to provide oral informed consent
  • Male or female, aged 18 to \<=75 years
  • Presence of CKD (2 eGFRs \<60, 90 days apart) and at least 1 of the following: most recent eGFR less than 30 or KFRE greater than 10%
  • English speaking with adequate ability to hear and understand questions over the phone
  • Willing to comply with all study procedures and be available for the duration of the study

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Wake Forest University Health Sciences
Coordinator of this site? Confirm its status
Winston-SalemUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.